NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 153 filers reported holding NOVAVAX INC in Q4 2014. The put-call ratio across all filers is 6.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $0 | -100.0% | 88 | -99.9% | 0.00% | -100.0% |
Q4 2018 | $271,000 | +594.9% | 147,128 | +604.8% | 0.01% | +550.0% |
Q3 2018 | $39,000 | -78.3% | 20,875 | -84.5% | 0.00% | -77.8% |
Q2 2018 | $180,000 | -23.7% | 134,279 | +19.7% | 0.01% | -35.7% |
Q1 2018 | $236,000 | +353.8% | 112,215 | +350.7% | 0.01% | +366.7% |
Q3 2016 | $52,000 | -81.8% | 24,900 | -55.1% | 0.00% | -81.2% |
Q1 2016 | $286,000 | +1091.7% | 55,482 | +1860.5% | 0.02% | +1500.0% |
Q4 2015 | $24,000 | -94.3% | 2,830 | -95.3% | 0.00% | -95.2% |
Q3 2015 | $423,000 | +4.4% | 59,831 | +22.2% | 0.02% | +5.0% |
Q1 2015 | $405,000 | +48.4% | 48,972 | -25.3% | 0.02% | +17.6% |
Q3 2014 | $273,000 | – | 65,515 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alden Global Capital LLC | 600,000 | $4,362,000 | 3.76% |
DAFNA Capital Management LLC | 550,000 | $3,999,000 | 3.17% |
BB BIOTECH AG | 8,330,000 | $60,559,000 | 2.39% |
HARVEY CAPITAL MANAGEMENT INC | 602,750 | $4,381,000 | 2.20% |
NORTHPOINTE CAPITAL LLC | 2,124,035 | $15,442,000 | 1.82% |
Cormorant Asset Management, LP | 1,619,608 | $11,775,000 | 1.67% |
WILLIAM HARRIS INVESTORS INC | 667,922 | $4,856,000 | 1.22% |
Eventide Asset Management | 2,179,700 | $15,846,000 | 0.97% |
SECTORAL ASSET MANAGEMENT INC | 912,305 | $6,632,000 | 0.68% |
Rock Springs Capital Management LP | 852,500 | $6,198,000 | 0.46% |